97056 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
Immunointeractive molecules
#1802Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
#1803Combination gene for use in inhibiting cancerous cell growth
#1804Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
#1805Fibroblast growth factor receptors and methods for their use
#1806Pharmaceutical composition comprising TrkAIg2 for use in the prevention and/or treatment of cancer
#1807Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
#1808MATERIALS AND METHODS FOR TREATING OCULAR-RELATED DISORDERS
#1809Chimeric Heteromultimer Adhesins
#1810C/EBPalpha gene targeting constructs and uses thereof
#1811Pharmaceutical compositions and methods of using secreted frizzled related protein
#1812Wnt-frizzled chimera
#1813Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
#1814Therapeutic agent for NGF
#1815Therapeutic agent for NGF
#1816Chimeric peptides comprising HER-2 B-cell epitopes and measles virus fusion protein T-cell epitopes
#1817Expression Vectors and Methods
#1818Growth differentiation factor-16
#1819Epidermal growth factor receptor mutations
#1820Compositions and Methods for the Diagnosis and Treatment of Tumor
#1821Expression Vectors and Methods
#1822Soluble ectodomain fragments of MET and uses thereof
#1823VEGF-related protein
#1824BMP pathway methods and compositions
#1825EGR-EGFR complex
#1826Peptide that inhibits janus kinase
#1827Vaccine-induced hepatitis B viral strain and uses thereof
#1828Tek antagonists
#1829IGF binding proteins
#1830IGF binding proteins
#1831Antibodies which activate an erythropoietin receptor
#1832TGFβ1-inhibitor peptides
#1833Inhibitor of vascular endothelial cell growth factor
#1834Epidermal growth factor receptor polypeptides and antibodies
#1835Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
#1836Targets for tumor growth inhibition
#1837Cell surface receptor isoforms and methods of identifying and using the same
#1838Fusion proteins comprising tumor necrosis factor receptor
#1839Peptide epitopes common to antigens of the same multigene family
#1840Polypeptide for the treatment of cancer and a method for preparation thereof
#1841Modulators and modulation of the interaction between RGM and Neogenin
#1842Antagonists of neuropilin receptor function and use thereof
#1843Treatment of Duchenne muscular dystrophy with myoblasts expressing dystrophin and treated to block myostatin signaling
#1844TGF-beta type receptor cDNAs encoded products and uses therefor
#1845Purification of HER-2 variants
#1846Rhesus HER2/neu, nucleotides encoding same, and uses thereof
#1847Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis
#1848Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
#1849Truncated EGF receptor
#1850METHODS FOR THE DIAGNOSIS AND TREATMENT OF METASTATIC PROSTATE TUMORS
#1851VEGF antagonist formulations
#1852KDR peptides and vaccines comprising the same
#1853GFRalpha3 and its uses
#1854EPH-like receptor protein tyrosine kinases
#1855Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)
#1856Polypeptide for the treatment of cancer and a method for preparation thereof
#1857Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity
#1858Therapeutic combination of a VEGF antagonist and anti-hypertensive agent
#1859Methods and materials for characterizing and modulating interaction between heregulin and HER3
#1860Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
#1861Method of treating eye injury with local administration of a VEGF inhibitor
#1862Peptide antagonists of vascular endothelial growth factor
#1863Glial cell line-derived neurotrophic factor receptor
#1864Method, compositions and classification for tumor diagnostics and treatment
#1865Mammalian neuralized family transcriptional regulators and uses
#1866Use of a vegf receptor gener or gene product
#1867Methods for preventing or treating a condition or a disease associated with angiogenesis
#1868Isolation and method of using tissue growth-inducing Frzb
#1869VEGF-binding fusion proteins and nucleic acids encoding the same
#1870Netrin receptors
#1871Polynucleotides encoding GDNFRα
#1872Erbb4 co-crystal
#1873VEGF-related protein
#1874Fibroblast growth factor receptors and methods for their use
#1875Structured peptide scaffold for displaying turn libraries on phage
#1876Methods for diagnosis and treatment of MDK1 signal transduction disorders
#1877Tumor-specific promoter
#1878Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions
#1879Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#1880Method of detecting a neoplasia associated with an activating platelet derived growth factor receptor alpha (PDGFRA) mutation
#1881Regulated transcription of targeted genes and other biological events
#1882Methods of detecting opioid growth factor receptor (OGFr) in tissue
#1883Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides
#1884Monoclonal antibodies to activated erbB family members and methods of use thereof
#1885Isolation and use of solid tumor stem cells
#1886Rat neurotrophic factor receptor, GFR α-4
#1887Crystal structure of the complex of hepatocyte growth factor beta chain with Met receptor and methods of use
#1888ActRII receptor polypeptides, methods and compositions
#1889VEGF-binding fusion proteins and nucleic acids encoding the same
#1890Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
#1891Isolation and use of solid tumor stem cells
#1892Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
#1893Regulated apoptosis
#1894Use of VEGF inhibitors for treatment of eye disorders
#1895ALK7 and myostatin inhibitors and uses thereof
#1896VEGFR-3 fusion proteins
#1897Prevention and treatment of cardiovascular pathologies
#1898γ-heregulin
#1899C-erbB-2 external domain: gp75
#1900Methods of indentifying modulators of the FGF receptor
#1901Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
#1902Methods for therapeutic vaccination
#1903Method of identifying transmembrane protein-interacting compounds
#1904Wound healing
#1905Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#1906Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
#1907Method of administering and using VEGF inhibitors for the treatment of malignant pleural effusion
#1908Polypeptide for the treatment of cancer and a method for preparation thereof
#1909Method of administering and using VEGF inhibitors for the treatment of human cancer
#1910Treatments for cancer
#1911BMP pathway methods and compositions
#1912Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
#1913TGF-beta type receptor cDNAs encoded products
#1914Ephrin-B receptor protein involved in carcinoma
#1915Use of VEGF inhibitors for treatment of eye disorders
#1916Transgenic non-human animals expressing a truncated activin type II receptor
#1917Method of modulating tissue growth using Frzb protein
#1918Antibodies to EGF receptor epitope peptides
#1919Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof
#1920Vascular endothelial cell growth factor antagonists and uses thereof
#1921Compositions and methods for inducing and regulating bone formation
#1922Intron fusion proteins, and methods of identifying and using same
#1923Methods of antagonizing morphogens
#1924RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA)
#1925Compositions and methods for dendritic cell-based immunotherapy
#1926GFRalpha3 and its uses
#1927Use of an epitope of vascular endothelial growth factor receptor KDR/Flk-1
#1928Cripto antagonism of activin and TGF-b signaling
#1929Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
#1930Crystal structure of VEGFRKD: ligand complexes and methods of use thereof
#1931Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated
#1932Structure-based design and synthesis of FGF inhibitors and FGF modulator compounds
#1933Expressed ligand-vascular intercellular signaling molecule
#1934Cloning and recombinant production of CRF receptor(s)
#1935Method for obtaining mastocyte lines from pig tissues and for producing heparin-type molecules
#1936Angiogenesis inhibitors
#1937Populations of cells that express flk-2 receptors
#1938Active antiangiogenic therapy
#1939Methods of treating eye disorders with modified chimeric polypeptides
#1940Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
#1941Modified chimeric polypeptides with improved pharmacokinetic properties
#1942Antagonist peptides to VEGF receptor Flt-1
#1943Method for screening FGFR-4 agonists
#1944Fibroblast growth factor receptor activating gene 1 and related compositions and methods
#1945IGF binding proteins
#1946Cells expressing anti-Fc receptor binding components
#1947Polynucleotides encoding novel ErbB-2 polypeptides and kits and methods using same
#1948Drug for regenerating tissue and vessel and method therefor
#1949Fibroblast growth factor receptors and methods for their use
#1950Methods for identifying alpha PDGFR agonists and antagonists
#1951Cell line comprising vector encoding truncated FLK-1 receptor
#1952Methods and compositions for use in interventional pharmacogenomics
#1953Enhanced solubility of recombinant proteins
#1954Expressed ligand-vascular intercellular signaling molecule
#1955Viral vector encoding pigment epithelium-derived factor
#1956KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
#1957C/EBPalpha gene targeting constructs and uses thereof
#1958Oligomeric molecules and uses thereof
#1959Ret ligand (RetL) for stimulating neural and renal growth
#1960Manipulatin of oocyte maturation and male germ cell survival
#1961Polypeptide purification method
#1962Vascular endothelial cell growth factor antagonists and uses thereof
#1963Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use
#1964VEGF inhibitor polypeptides
#1965Methods for treatment or diagnosis of disease or disorders associated with an APB domain
#1966Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
#1967Prognostic evaluation of cancer
#1968DNA vaccine containing tumor-associated gene and cytokine gene and method of preparation the same
#1969Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof
#1970Growth differentiation factor-16
#1971Fibroblast growth factor receptors and methods for their use
#1972Expression vectors and methods
#1973Monoclonal antibodies specific to VEGF receptors and uses thereof
#1974Method of treating corneal transplant rejection
#1975Methods and compositions for treating hcap associated diseases
#1976Populations of cells that express FLK-1 receptors
#1977Treatments for ocular neovascularization
#1978Composition comprising aflibercept and a variant thereof, and related methods and uses
#1979ACTRIIB ligand trap compositions and uses thereof
#1980Fragments of growth hormone binding protein